Tretinoin

Overview

Tretinoin is a dermatological agent used to treat acne vulgaris and acute promyelocytic leukemia. It is a derivative of vitamin A and works by modulating cell differentiation and proliferation.

API suppliers (7)

Suppliers of Tretinoin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany1 active DMF
• SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany1 active DMF
• SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany1 active DMF
• Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
• OLON SPAItaly1 active DMF
• RANBAXY LABORATORIES LTD
• SHANGHAI NO 6 PHARMACEUTICAL FACTORY

Patent & exclusivity (US)

Per the FDA Orange Book (37 approved US products), the latest listed US patent on Tretinoin expires 21 Aug 2038. Generic API sourcing typically opens up once these lapse.

Therapeutic areas